Dr. Francois Lebel
About Dr. Francois Lebel
Dr. Francois Lebel Chief Medical Officer
Dr. Francois Lebel is the Chief Medical Officer (CMO) at his current organization. With substantial experience in the pharmaceutical industry, he has previously held similar leadership roles. His responsibilities involve overseeing all aspects of medical and clinical affairs, ensuring that medical practices align with the latest research and regulatory standards. Dr. Lebel's expertise as a CMO is bolstered by his extensive background in research and development, as well as his strong educational foundation in internal medicine.
Education and Training of Dr. Francois Lebel
Dr. Francois Lebel received his medical degree from the University of Ottawa, Canada. Following this, he pursued postgraduate training at McGill University and Harvard Medical School, which provided him with advanced and specialized knowledge in internal medicine. Dr. Lebel's educational credentials are further strengthened by his status as a Board Certified physician in Internal Medicine and his recognition as a Fellow of the Royal College of Physicians of Canada.
Dr. Francois Lebel's Professional Background
Dr. Francois Lebel has held prominent positions in various leading pharmaceutical companies. Before his current role, he served as Executive Vice President, Research & Development and Chief Medical Officer at Spectrum Pharmaceuticals and ZIOPHARM Oncology. Additionally, Dr. Lebel has experience as the Vice President of Research & Development at Baxter International and as the Global Head of Medical and Scientific Affairs at MedImmune. His extensive professional background reflects his deep involvement in advancing medical research and improving clinical practices.
Achievements of Dr. Francois Lebel
Dr. Francois Lebel's career is marked by a series of significant roles in the pharmaceutical and medical research sectors. Being a Fellow of the Royal College of Physicians of Canada signifies his commitment to excellence in the field of internal medicine. His past leadership positions at Spectrum Pharmaceuticals, ZIOPHARM Oncology, Baxter International, and MedImmune highlight his influence in advancing medical research and development. Through these roles, Dr. Lebel has contributed to various research initiatives and strategic developments within the healthcare industry.